BRIEF published on 02/04/2026 at 19:58, 6 months 24 days ago Voting rights and shares of ABIONYX on Euronext Paris Euronext Paris Share Capital Voting Rights AMF ABIONYX
PRESS RELEASE published on 02/04/2026 at 19:53, 6 months 24 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement on total voting rights and shares. Company focuses on innovative medicines in rare diseases with lipid science expertise Shares Total Voting Rights Monthly Statement ABIONYX Pharma Innovative Medicines
PRESS RELEASE published on 02/04/2026 at 19:53, 6 months 24 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma communique le nombre total de droits de vote et d'actions en circulation, soulignant son engagement envers les maladies inflammatoires sévères sans traitement efficace Droits De Vote Actions Maladies Inflammatoires Biopharma ABIONYX Pharma
BRIEF published on 01/28/2026 at 18:53, 7 months ago ABIONYX: Publication of the Number of Voting Rights and Shares Euronext Paris Share Capital Voting Rights Financial Transparency ABIONYX
BRIEF published on 01/28/2026 at 18:53, 7 months ago ABIONYX : Publication du Nombre de Droits de Vote et d'Actions Euronext Paris Droits De Vote Capital Social Transparence Financière ABIONYX
PRESS RELEASE published on 01/28/2026 at 18:48, 7 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma communique le nombre de titres en circulation et de droits de vote, conformément aux réglementations en vigueur. Détails sur les actions et objectif de la société Droits De Vote Développement Biopharma ABIONYX Pharma Nombre De Titres
BRIEF published on 01/23/2026 at 19:05, 7 months 5 days ago ABIONYX Pharma Announces 2026 Financial Calendar Financial Calendar Biopharma ABIONYX Pharma 2026 Updates Sepsis Care
BRIEF published on 01/23/2026 at 19:05, 7 months 5 days ago ABIONYX Pharma unveils its 2026 financial calendar Critical Care Innovative Therapies ABIONYX Pharma Sepsis Financial Calendar 2026
BRIEF published on 01/23/2026 at 19:05, 7 months 5 days ago ABIONYX Pharma annonce son calendrier financier pour 2026 Calendrier Financier Biopharma ABIONYX Pharma Mises À Jour 2026 Soins De La Septicémie
BRIEF published on 01/23/2026 at 19:05, 7 months 5 days ago ABIONYX Pharma dévoile son calendrier financier 2026 ABIONYX Pharma Sepsis Thérapies Innovantes Calendrier Financier 2026 Soins Critiques
Published on 08/28/2026 at 14:00, 6 hours 26 minutes ago Lobe Sciences Expands Leadership Team with New CFO Appointment
Published on 08/28/2026 at 13:00, 7 hours 26 minutes ago Abasca Files NI 43-101 Technical Report, Commences Summer Exploration Program at Loki and Elects to File Semi-annual Interim Financial Statements and Related MD&A
Published on 08/28/2026 at 08:05, 12 hours 21 minutes ago Caledonia Mining Corporation Plc: Maiden Mineral Resource Estimate at Motapa 379,000 oz Measured and Indicated; 131,000 oz Inferred
Published on 08/28/2026 at 08:05, 12 hours 21 minutes ago Tocvan Announces New Surface Mineralization in Several Zones at Gran Pilar Gold-Silver Project
Published on 08/28/2026 at 08:00, 12 hours 26 minutes ago Caledonia Mining Corporation Plc: Blanket Mine Underground Measured and Indicated Mineral Resources Estimate Increases by 22% to 2.18 Million Ounces and Declaration of a Surface Mineral Resource Estimate
Published on 08/28/2026 at 19:10, 1 hour 15 minutes ago Invitation to Professional or Qualified Investors holding Notes to submit offers for Branicks Bridge Notes and VIB Bridge Notes
Published on 08/28/2026 at 18:01, 2 hours 24 minutes ago CPI Europe announces unaudited results for the first half of 2026
Published on 08/28/2026 at 18:00, 2 hours 26 minutes ago Highlight Event and Entertainment AG publishes results for the first half of 2026
Published on 08/28/2026 at 18:00, 2 hours 26 minutes ago Investis successfully issues a fixed rate bond of CHF 100 million
Published on 08/28/2026 at 18:00, 2 hours 26 minutes ago Investis émet avec succès un emprunt obligataire à taux fixe d’un volume de CHF 100 millions
